Log in to save to my catalogue

Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe as...

Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe as...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b505610b58c54b7e807528151f52ae31

Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma

About this item

Full title

Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-04, Vol.11 (1), p.8425-8425, Article 8425

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Some patients with severe asthma experience exacerbations despite receiving multiple therapy. The risk of exacerbation and heterogeneous response to treatment may be associated with specific inflammatory molecules that are responsive or resistant to corticosteroids. We aimed to identify the independent factors predictive for the future risk of exac...

Alternative Titles

Full title

Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b505610b58c54b7e807528151f52ae31

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b505610b58c54b7e807528151f52ae31

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-86179-1

How to access this item